🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for HIV Infection Primary

Natural History of KSHV-Associated Multicentric Castleman s Disease NCT04968288n/a1 site📍 Bethesda National Cancer Institute (NCI) Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. NCT04160455n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: expression of a panel Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging NCT05602376NA2 sites📍 East London📍 Cape Town Desmond Tutu HIV Foundation · Tests: U=U testing messaging scripts, U=U adherence messaging scripts A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs). NCT04319367Phase 212 sites📍 Aarhus📍 Brighton📍 Edinburgh Imperial College London · Tests: Investigational Medicinal Product T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) NCT06343311Phase 1, Phase 25 sites📍 Sacramento📍 Cleveland📍 Portland Estrella Immunopharma, Inc. · Tests: EB103 Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites📍 Duarte📍 Chicago📍 New York AIDS Malignancy Consortium · Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women. NCT02956031n/a1 site📍 Pretoria University of Pretoria · Tests: Screening, Colposcopy, LLETZ Characterization of Acute and Recent HIV-1 Infections in Zurich. NCT00537966n/a1 site📍 Zurich University of Zurich Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control NCT05300035Phase 217 sites📍 Bobigny📍 Clamart📍 Clichy ANRS, Emerging Infectious Diseases · Tests: Recombinant human monoclonal antibody (bNAbs), Placebo Integrated Navigation Services for Treatment Adherence, Counseling, and Research NCT04663152NA1 site📍 Miami University of Miami · Tests: INSTACARE AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") NCT07649304Phase 11 site📍 Rockville National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography HIV/HBV/HCV Triple Screening in Primary Care NCT07031219NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: electronic medical record alert linked to orders Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer NCT00006518n/a1 site📍 Bethesda National Cancer Institute (NCI) Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa NCT05881447n/a1 site📍 Bagamoyo Swiss Tropical & Public Health Institute Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Daratumumab SC Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants NCT00039689n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Intervention to Enhance PrEP Persistence NCT06872307NA3 sites📍 Atlanta📍 Jackson📍 Providence Brown University · Tests: RAMP-It-Up Initiation, Adherence, and Retention Intervention Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment NCT05671718NA5 sites📍 Pietermaritzburg📍 Port Shepstone📍 East London Johns Hopkins University · Tests: Nurse-Led Treatment in Primary Care
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy